2015Journal of Clinical Pulmonary MedicineRequires access

Clinical effect of BACE combined with I~(125) seed in the treatment of patients with advanced lung cancer

XU Ren-lian

Open publisher page 0 citations

Abstract

Objective To observe the clinical effect of bronchial artery occlusion induced by BACE combined with I125 seed implantation in the treatment of advanced lung cancer. Methods 39 cases of bronchial artery occlusion after BACE treatment were selected,and they were implanted with I125 seed again in 30 days under CT guided percutaneous. Another 41 cases of BACE were treated as the control group. Results There were 17 cases of CR,19 cases of PR,and 3 cases of NC in the study group. The total response rate( CR + PR) was 92. 3% in the study group. The 3-month survival rate was 94. 2%,the 6-month survival rate was 91. 3%,and the 1-year survival rate was 83. 2% in the study group. There were 12 cases of CR,21 cases of PR,and 8 cases of NC in the control group. The total response rate( CR + PR) was 80. 4% in the control group. The 3-month survival rate was 93. 1%,the 6-month survival rate was 88. 4%,and the 1-year survival rate was 72. 6% in the control group. Conclusion BACE combined with I125 seed implantation under CT guided percutaneous is minimally invasive safe and shows higher total effective rate in the treatment of advanced lung cancer.

About this research paper

What this paper is about

Objective To observe the clinical effect of bronchial artery occlusion induced by BACE combined with I125 seed implantation in the treatment of advanced lung cancer. Methods 39 cases of bronchial artery occlusion after BACE treatment were selected,and they were implanted with I125 seed again in 30 days under CT guided percutaneous. Another 41 cases of BACE were treated as the control group. Results There were 17 cases of CR,19 cases of PR,and 3 cases of NC in the study group. The total response rate( CR + PR) was 92. 3% in the study group. The 3-month survival rate was 94. 2%,the 6-month survival rate was 91. 3%,and the 1-year survival rate was 83. 2% in the study group. There were 12 cases of CR,21 cases of PR,and 8 cases of NC in the control group. The total response rate( CR + PR) was 80. 4% in the control group. The 3-month survival rate was 93. 1%,the 6-month survival rate was 88. 4%,and the 1-year survival rate was 72. 6% in the control group. Conclusion BACE combined with I125 seed implantation under CT guided percutaneous is minimally invasive safe and shows higher total effective rate in the treatment of advanced lung cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical effect of bronchial artery occlusion induced by BACE combined with I125 seed implantation in the treatment of advanced lung cancer. Methods 39 cases of bronchial artery occlusion after BACE treatment were selected,and they were implanted with I125 seed again in 30 days under CT guided percutaneous. Another 41 cases of BACE were treated as the control group. Results There were 17 cases of CR,19 cases of PR,and 3 cases of NC in the study group. The total response rate( CR + PR) was 92. 3% in the study group. The 3-month survival rate was 94. 2%,the 6-month survival rate was 91. 3%,and the 1-year survival rate was 83. 2% in the study group. There were 12 cases of CR,21 cases of PR,and 8 cases of NC in the control group. The total response rate( CR + PR) was 80. 4% in the control group. The 3-month survival rate was 93. 1%,the 6-month survival rate was 88. 4%,and the 1-year survival rate was 72. 6% in the control group. Conclusion BACE combined with I125 seed implantation under CT guided percutaneous is minimally invasive safe and shows higher total effective rate in the treatment of advanced lung cancer.

Key concepts: Medicine, Survival rate, Lung cancer, Percutaneous, Occlusion, Surgery, Urology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical effect of BACE combined with I~(125) seed in the treatment of patients with advanced lung cancer — Research Paper | ScholarLens